Cargando…
3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase
BACKGROUND: Glioblastoma (GBM) is the most common, malignant, and lethal primary brain tumor in adults accounting for about 50% of all gliomas. Up to now, the chemotherapy approaches for GBM were limited. 3-O-acetyl-11-keto-β-boswellic acid (AKBA), the major active ingredient of the gum resin from B...
Autores principales: | Li, Wan, Liu, Jinyi, Fu, Weiqi, Zheng, Xiangjin, Ren, Liwen, Liu, Shiwei, Wang, Jinhua, Ji, Tengfei, Du, Guanhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029111/ https://www.ncbi.nlm.nih.gov/pubmed/29970196 http://dx.doi.org/10.1186/s13046-018-0805-4 |
Ejemplares similares
-
Correction: 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase
por: Li, Wan, et al.
Publicado: (2022) -
3-O-Acetyl-11-keto-β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma
por: Li, Wan, et al.
Publicado: (2020) -
Measurement of 3-acetyl-11-keto-beta-boswellic acid and 11-keto-beta-boswellic acid in Boswellia serrata Supplements Administered to Dogs
por: Miscioscia, Erin, et al.
Publicado: (2019) -
Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells
por: Conti, Sefora, et al.
Publicado: (2018) -
Antiproliferative and cell cycle arrest potentials of 3-O-acetyl-11-keto-β-boswellic acid against MCF-7 cells in vitro
por: Ahmed, Saja A., et al.
Publicado: (2023)